glp-1 structure Drugs and the Physiology of Metabolic Health How GLP-1 Receptor Agonists Evolved

Semaglutide GLP-1 injections are used to treat adults with weight-related conditions such as type 2 diabetes

Schlachetzki JCM: chronic peripheral inflammation: a possible contributor to neurodegenerative diseases

Phipps said he's confident that patients can take MariTide even less frequently, such as once a quarter, to maintain the weight loss they saw after starting the drug

People taking Wegovy lost an average of about 15% of their body weight over 68 weeks

SNAC is found in breast milk, and its effects on breastfeeding infants are unknown

Weight loss that exceeds 5% of total body weight within a month is a trigger for evaluation (Schweitzer 2026)